Personalized care with customized immune response diagnostics

The entire healthcare industry is focused on improving patient care with the introduction of new Personalized Treatments. We at ImmunoDiagnostics want to play a role in shaping the Personalized future.

With this in mind, we have taken steps towards becoming a leading partner in development with the pharmaceutical industry. As the basis for companion diagnostic partnerships in immune response diagnostics, we have dedicated our extensive portfolio of clinical platforms and assay development services to the pharmaceutical industry. We develop collaborations with clinical and assay development departments – from basic BioMarker research to solutions for doctors’ offices with our point-of-care testing.

Working with ImmunoDiagnostics gives our partners access not only to several cutting-edge technologies, but to global distribution and regulatory expertise that facilitate technical developments and the commercialisation of companion diagnostic products.

With our medical expertise as well as the platforms that we have to offer, we can provide the best support for our partners.

Interested?

For more detailed information regarding Pharmaceutical and Healthcare Collaborations, please get in touch with ImmunoDiagnostics in Uppsala, Sweden on e-mail address pdb@phadia.com.

Commercial terms

Pharmaceutical and Healthcare Collaborations operates in accordance with normal industrial practices, including clear quotations, secrecy agreements and, if desired, contracts developed together with the client.

As in all diagnostic testing, the diagnosis is made by the physican based on both test results and the patient history.